HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells

By Kunieda Y.   Nakagawa K.   Nishimura H.   Kato H.   Ukimura N.   Yano S.   Kawano H.   Kimura S.   Nakagawa M.   Tsuji H.  

Thrombosis Research, Vol. 110, Iss. 4, 2003-06 ,pp. : 227-234

Elsevier

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitor Prevents Plasminogen Activator Inhibitor-1 Expression in a Rat Model with Cardiovascular Remodeling Induced by Chronic Inhibition of Nitric Oxide Synthesis

By Katoh M.   Egashira K.   Mitsui T.   Chishima S.   Takeshita A.   Narita H.  

Journal of Molecular and Cellular Cardiology, Vol. 32, Iss. 1, 2000-01 ,pp. : 73-83

Academic Press

Access to resources Recommend Favorite

Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications

By  

Medical Principles and Practice, Vol. 18, Iss. 4, 2009-06 ,pp. : 266-271

Karger

Access to resources Recommend Favorite

Molecular Advances in Plasminogen Activator Inhibitor 1 Interaction with Thrombin and Tissue-Type Plasminogen Activator

By Stoop A.   van Meijer M.   Horrevoets A.J.G.   Pannekoek H.  

Trends in Cardiovascular Medicine, Vol. 7, Iss. 2, 1997-02 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells

By Grimsley P.G.   Normyle J.F.   Brandt R.A.   Joulianos G.   Chesterman C.N.   Hogg P.J.   Owensby D.A.  

Thrombosis Research, Vol. 79, Iss. 4, 1995-08 ,pp. : 353-361

Elsevier

Access to resources Recommend Favorite